BioCentury This Week

BioCentury Podcasts
  • 0,0 (0)
  • SCIENCE DE LA VIE
  • CHAQUE SEMAINE
BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

  1. Ep. 281 - Roche Reboot and 5 Things on Trump 2.0

    -6 H

    Ep. 281 - Roche Reboot and 5 Things on Trump 2.0

    Once pharma’s oncology powerhouse, Roche is charting a new course that extends beyond its traditional stronghold in cancer therapeutics. On the latest BioCentury This Week podcast, BioCentury’s editors discuss how the Swiss pharma has reshaped its strategy for long-term growth. They also discuss another tumultuous weekend for staff at FDA and NIH, as well as the challenges of precision medicine for psychiatric conditions. View full story: https://www.biocentury.com/article/655157 00:00 - In...

    22 min
  2. Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs

    -6 J

    Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs

    Rather than fretting over increasing competition from Chinese life sciences companies, biotechs in the U.S. should rise to the challenge and learn from their competitors. On the latest BioCentury This Week podcast, BioCentury’s editors discuss the increasing pace of innovation from China and how U.S. biotechs need to meet the moment, delivering key takeaways from Editor in Chief Simone Fishburn’s fireside chat with industry leader John Maraganore at the BIO CEO & Investor Forum in New Yor...

    28 min
  3. Ep. 279 - East-West Summit Preview

    15 FÉVR.

    Ep. 279 - East-West Summit Preview

    Western VCs are paying more attention than ever to innovation emerging from Asia — from antibody-drug conjugates to bispecifics, AI and beyond — as the NewCo Model becomes the latest trend to bridge talent, assets and venture money across the Pacific and on to North America and Europe. On a special edition of BioCentury This Week podcast, a trio of leaders from Asia’s life sciences ecosystem — Khoo Shih of Singaporean investor ClavystBio, McKinsey & Company’s Anirudh Roy Popli and Wendy P...

    30 min
  4. Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine

    11 FÉVR.

    Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine

    White House plans to slash FDA and NIH risk decimating two agencies at the core of U.S. biomedical innovation. On the latest BioCentury This Week podcast, BioCentury’s editors assess draft plans by the Trump administration that seek to halve FDA staff, cut NIH, and reduce overhead payments to academic institutions. The policy addressed in a recent Guest Commentary for BioCentury, “Defending the NIH, the NSF and the foundation of American science,” by the Scleroderma Research Foundation’s Luke...

    26 min
  5. Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug

    4 FÉVR.

    Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug

    The boom in the creation of companies that were launched in the West based on assets sourced in Asia signals China’s galloping speed of innovation. On the latest BioCentury This Week podcast, BioCentury’s editors discuss the “NewCo Model,” who the players are, from CEOs and companies to investors; the areas of innovation the start-ups are tackling; and the evolution of the trend. (Read about the company that kicked off the trend, Arrivent, here.) The editors also assess how personnel losses a...

    25 min
  6. Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler

    31 JANV.

    Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler

    Psychiatric drug development has had major wins over the past year-and-a-half — think Karuna Pharmaceuticals' $14 billion takeout by Bristol Myers Squibb and the subsequent launch of a new schizophrenia therapy — but targeted neuropsychiatric drug development is still in its infancy. On a special edition of the BioCentury This Week podcast, BioCentury’s editors detail the promise of precision medicine in the space and break down what recent setbacks for key players mean for next steps in the ...

    21 min
  7. Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH

    28 JANV.

    Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH

    BioCentury’s analysis of the technologies behind last year’s biotech series A raisers sees progress in nanoparticles, CAR cell therapies, degraders and antibody-drug conjugates. On the latest BioCentury This Week podcast, BioCentury’s editors discuss the trends spotted in 2024’s crop of more than 150 series A rounds — from top therapeutic areas and modalities to the leading investors funding the innovation. The editors turn to Washington for takeaways from BioCentury’s “exit interview” with P...

    33 min
  8. Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI

    22 JANV.

    Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI

    With political uncertainty overshadowing market sentiment going into 2025, BioCentury’s editorial team assesses the bull and bear arguments for biotech in the New Year on the BioCentury This Week podcast’s Public Markets Preview. Will continued uncertainty drive biotech sentiment in the coming months, or will the bear arguments fail to manifest, stymied by M&A and other positive factors? In the second part of the 2025 Preview, BioCentury’s editors highlight some of the key catalysts in bi...

    36 min
Tout afficher (291)

À propos

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Informations

  • Chaîne
    BioCentury Podcasts
  • Création
    BioCentury
  • Années d’activité
    2020 - 2025
  • Épisodes
    291
  • Classification
    Tous publics
  • Copyright
    © 2025 BioCentury Inc. All Rights Reserved.
  • Site web de l’émission
    BioCentury This Week

Plus de contenus par BioCentury Podcasts

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada